Retraction Note: Letter to Editor, “The effects of dabrafenib and/or trametinib treatment in Braf V600mutant glioma: a systematic review and metaanalysis”

被引：0
|
作者：
Hethesh Chellapandian [1 ]
Sivakamavalli Jeyachandran [1 ]
机构：
[1] Saveetha Dental College and Hospital,Lab in Biotechnology and Biosignal Transduction, Department of Orthodontics
[2] Saveetha Institute of Medical and Technical Sciences (SIMATS),undefined
来源：
Neurosurgical Review | / 48卷 / 1期
关键词：
D O I：
10.1007/s10143-025-03284-9
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [31] Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy)
    Massimo Aglietta
    Vanna Chiarion-Sileni
    Paolo Fava
    Massimo Guidoboni
    Roberta Depenni
    Alessandro Minisini
    Francesca Consoli
    Paolo Ascierto
    Gaetana Rinaldi
    Maria Banzi
    Riccardo Marconcini
    Rossana Gueli
    Virginia Ferraresi
    Marco Tucci
    Giuseppe Tonini
    Giovanni Lo Re
    Michele Guida
    Michele Del Vecchio
    Ilaria Gioia Marcon
    Paola Queirolo
    Targeted Oncology, 2021, 16 : 789 - 799
  • [32] Primary analysis of a phase II trial of dabrafenib plus trametinib (dab plus tram) in BRAF V600 mutant pediatric low-grade glioma (pLGG).
    Bouffet, Eric
    Hanford, Jordan
    Garre, Maria Luisa
    Hara, Junichi
    Plant-Fox, Ashley
    Aerts, Isabelle
    Locatelli, Franco
    Van der Lugt, Jasper
    Papusha, Ludmila
    Sahm, Felix
    Tabori, Uri
    Cohen, Kenneth J.
    Packer, Roger J.
    Witt, Olaf
    Sandalic, Lali
    da Silva, Ana Bento Pereira
    Russo, Mark W.
    Hargrave, Darren R.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (17)
  • [33] Treatment of BRAF V600E mutant gastrointestinal stromal tumor with dabrafenib: a case report
    Gowda, Sonia
    Sandow, Lyndsey
    Heinrich, Michael C.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (02) : 788 - 793
  • [34] TREATMENT OF THREE DIFFERENT BRAF-V600E POSITIVE BRAIN TUMORS WITH VEMURAFENIB AND DABRAFENIB/TRAMETINIB: A CASE SERIES
    Dhir, Nikita
    Chandrahas, Sheila
    O'Suoji, Chibuzo
    Al-Rahawan, Mohamad
    NEURO-ONCOLOGY, 2020, 22 : 90 - 90
  • [35] Dabrafenib Plus Trametinib for BRAF V600E-Mutant Non-small Cell Lung Cancer: A Patient Case Report
    Janet Pan
    Clinical Drug Investigation, 2019, 39 : 1003 - 1007
  • [36] EFFECTIVENESS OF BRAF INHIBITORS IN PATIENTS WITH BRAF V600 MUTATION POSITIVE GLIOMA: A SYSTEMATIC REVIEW
    Yao, Ian
    Dawson, Sarah
    Higgins, Julian
    McGuinness, Luke
    McAleenan, Alexandra
    Kurian, Kathreena M.
    NEURO-ONCOLOGY, 2019, 21 : 14 - 14
  • [37] Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II)
    Atkinson, Victoria
    Sandhu, Shahneen
    Hospers, Geke
    Long, Georgina, V
    Aglietta, Massimo
    Ferrucci, Pier F.
    Tulyte, Skaiste
    Cappellini, Gian Carlo Antonini
    Soriano, Virtudes
    Ali, Sayed
    Poprach, Alexandr
    Cesas, Alvydas
    Rodriguez-Abreu, Delvys
    Lau, Mike
    de Jong, Egbert
    Legenne, Philippe
    Stein, Dara
    King, Brianna
    van Thienen, Johannes, V
    MELANOMA RESEARCH, 2020, 30 (03) : 261 - 267
  • [38] Dabrafenib Plus Trametinib for BRAF V600E-Mutant Non-small Cell Lung Cancer: A Patient Case Report
    Pan, Janet
    CLINICAL DRUG INVESTIGATION, 2019, 39 (10) : 1003 - 1007
  • [39] EFFICACY AND SAFETY OF DABRAFENIB plus TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E-MUTATED HIGH-GRADE GLIOMA (HGG)
    Wen, Patrick
    Alexander, Stein
    Yung-Jue, Bang
    van den Bent, Martin
    Gazzah, Anas
    Dietrich, Sascha
    de Vos, Filip
    van Linde, Mayra
    Lai, Albert
    Chi, Andrew
    Prager, Gerald
    Campone, Mario
    von Bubnoff, Nikolas
    Fasolo, Angelica
    Lopez-Martin, Jose
    Mookerjee, Bijoyesh
    Boran, Aislyn
    Burgess, Paul
    Rangwala, Fatima
    Subbiah, Vivek
    NEURO-ONCOLOGY, 2018, 20 : 238 - 238
  • [40] Redifferentiation of BRAF V600E-Mutated Radioiodine Refractory Metastatic Papillary Thyroid Cancer After Treatment With Dabrafenib and Trametinib
    Jafri, Sabih
    Yaqub, Abid
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
12345